{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:13:26Z","timestamp":1791605606448,"version":"4.3.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100024161","name":"Universidade do Algarve","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100024161","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Obesity is a known risk factor cardiovascular disease, type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH), characterized by a state of chronic inflammation. In this stress context, many hepatokines and adipokines may be released, including Growth Differentiation Factor 15 (GDF15). GDF15 is involved in the regulation of appetite and metabolism, showing potential for the treatment of obesity and related comorbidities. This review aimed to evaluate the impact of bariatric and metabolic surgery (BMS) in the levels of circulating GDF15 in individuals with obesity. Considering the studies available, reporting GDF15 levels before and 12 months after BMS, the profile of GDF15 changes was not a consensus, and was not fully explained by differences in the characterization of the population in each study. This review also discusses the multiple sources of GDF15 in obesity and in response to its surgical treatment, where pathological, pharmacological, and behavioral factors may all be important contributors.<\/jats:p>","DOI":"10.1007\/s13105-026-01160-8","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:30:24Z","timestamp":1774945824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The impact of bariatric and metabolic surgery on the levels of circulating growth differentiation factor 15 in humans"],"prefix":"10.1007","volume":"82","author":[{"given":"Victor","family":"Yassuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Sequeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Lu\u00edsa","family":"De Sousa-Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"3","key":"1160_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA et al (2025) Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol 13(3):221\u2013262","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"1160_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/met.2015.0095","volume":"13","author":"P Manna","year":"2015","unstructured":"Manna P, Jain SK (2015) Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: causes and therapeutic strategies. Metab Syndr Relat Disord 13(10):423\u201344","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"1160_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s10020-024-01019-y","volume":"30","author":"MS Islam","year":"2024","unstructured":"Islam MS, Wei P, Suzauddula M, Nime I, Feroz F, Acharjee M et al (2024) The interplay of factors in metabolic syndrome: understanding its roots and complexity. Mol Med 30(1):279","journal-title":"Mol Med"},{"issue":"1","key":"1160_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel AR, Olefsky JM (2017) Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest 127(1):1\u20134","journal-title":"J Clin Invest"},{"key":"1160_CR5","doi-asserted-by":"crossref","unstructured":"Ren Y, Zhao H, Yin C, Lan X, Wu L, Du X et al (2022) Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation. Front Endocrinol (Lausanne). ;13","DOI":"10.3389\/fendo.2022.873699"},{"issue":"12","key":"1160_CR6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.soard.2022.08.013","volume":"18","author":"D Eisenberg","year":"2022","unstructured":"Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV et al (2022) 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis 18(12):1345\u201356","journal-title":"Surg Obes Relat Dis"},{"key":"1160_CR7","doi-asserted-by":"crossref","unstructured":"Picot J, Jones J, Colquitt J, Gospodarevskaya E, Loveman E, Baxter L et al (2009) The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess (Rockv). ;13(41)","DOI":"10.3310\/hta13410"},{"issue":"3","key":"1160_CR8","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.soard.2018.12.002","volume":"15","author":"TK Fakhry","year":"2019","unstructured":"Fakhry TK, Mhaskar R, Schwitalla T, Muradova E, Gonzalvo JP, Murr MM (2019) Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis. Surg Obes Relat Dis 15(3):502\u2013511","journal-title":"Surg Obes Relat Dis"},{"issue":"21","key":"1160_CR9","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","volume":"94","author":"MR Bootcov","year":"1997","unstructured":"Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY et al (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-\u03b2 superfamily. Proc Natl Acad Sci 94(21):11514\u201311519","journal-title":"Proc Natl Acad Sci"},{"issue":"16","key":"1160_CR10","doi-asserted-by":"publisher","first-page":"8889","DOI":"10.3390\/ijms22168889","volume":"22","author":"L Rochette","year":"2021","unstructured":"Rochette L, Dogon G, Zeller M, Cottin Y, Vergely C (2021) GDF15 and Cardiac Cells: Current Concepts and New Insights. Int J Mol Sci 22(16):8889","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1160_CR11","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.3390\/cells10112990","volume":"10","author":"K Johann","year":"2021","unstructured":"Johann K, Kleinert M, Klaus S (2021) The Role of GDF15 as a Myomitokine. Cells 10(11):2990","journal-title":"Cells"},{"key":"1160_CR12","doi-asserted-by":"crossref","unstructured":"Plomgaard P, Hansen JS, Townsend LK, Gudiksen A, Secher NH, Clemmesen JO et al (2022) GDF15 is an exercise-induced hepatokine regulated by glucagon and insulin in humans. Front Endocrinol (Lausanne). ;13","DOI":"10.3389\/fendo.2022.1037948"},{"issue":"4","key":"1160_CR13","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1210\/en.2008-0952","volume":"150","author":"Q Ding","year":"2009","unstructured":"Ding Q, Mracek T, Gonzalez-Muniesa P, Kos K, Wilding J, Trayhurn P et al (2009) Identification of Macrophage Inhibitory Cytokine-1 in Adipose Tissue and Its Secretion as an Adipokine by Human Adipocytes. Endocrinology 150(4):1688\u20131696","journal-title":"Endocrinology"},{"issue":"3","key":"1160_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cmet.2018.07.018","volume":"28","author":"VWW Tsai","year":"2018","unstructured":"Tsai VWW, Husaini Y, Sainsbury A, Brown DA, Breit SN (2018) The MIC-1\/GDF15-GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases. Cell Metab 28(3):353\u2013368","journal-title":"Cell Metab"},{"issue":"10","key":"1160_CR15","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/nm.4393","volume":"23","author":"PJ Emmerson","year":"2017","unstructured":"Emmerson PJ, Wang F, Du Y, Liu Q, Pickard RT, Gonciarz MD et al (2017) The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat Med 23(10):1215\u20131219","journal-title":"Nat Med"},{"issue":"10","key":"1160_CR16","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/nm.4392","volume":"23","author":"SE Mullican","year":"2017","unstructured":"Mullican SE, Lin-Schmidt X, Chin C-N, Chavez JA, Furman JL, Armstrong AA et al (2017) GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat Med 23(10):1150\u20131157","journal-title":"Nat Med"},{"issue":"10","key":"1160_CR17","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/nm.4394","volume":"23","author":"L Yang","year":"2017","unstructured":"Yang L, Chang C-C, Sun Z, Madsen D, Zhu H, Padkj\u00e6r SB et al (2017) GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat Med 23(10):1158\u20131166","journal-title":"Nat Med"},{"issue":"1","key":"1160_CR18","doi-asserted-by":"publisher","first-page":"23993","DOI":"10.1038\/s41598-024-75107-8","volume":"14","author":"K Takeuchi","year":"2024","unstructured":"Takeuchi K, Yamaguchi K, Takahashi Y, Yano K, Okishio S, Ishiba H et al (2024) Hepatocyte-specific GDF15 overexpression improves high-fat diet-induced obesity and hepatic steatosis in mice via hepatic FGF21 induction. Sci Rep 14(1):23993","journal-title":"Sci Rep"},{"key":"1160_CR19","doi-asserted-by":"crossref","unstructured":"Laurens C, Parmar A, Murphy E, Carper D, Lair B, Maes P et al (2020) Growth and differentiation factor 15 is secreted by skeletal muscle during exercise and promotes lipolysis in humans. JCI Insight. ;5(6)","DOI":"10.1172\/jci.insight.131870"},{"issue":"7968","key":"1160_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-023-06249-4","volume":"619","author":"D Wang","year":"2023","unstructured":"Wang D, Townsend LK, DesOrmeaux GJ, Frangos SM, Batchuluun B, Dumont L et al (2023) GDF15 promotes weight loss by enhancing energy expenditure in muscle. Nature 619(7968):143\u2013150","journal-title":"Nature"},{"issue":"1","key":"1160_CR21","doi-asserted-by":"publisher","first-page":"6789","DOI":"10.1038\/s41598-018-25098-0","volume":"8","author":"KH Kim","year":"2018","unstructured":"Kim KH, Kim SH, Han DH, Jo YS, Lee Y, Lee M-S (2018) Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice. Sci Rep 8(1):6789","journal-title":"Sci Rep"},{"issue":"5","key":"1160_CR22","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.jcmgh.2023.07.009","volume":"16","author":"X Li","year":"2023","unstructured":"Li X, Huai Q, Zhu C, Zhang X, Xu W, Dai H et al (2023) GDF15 ameliorates liver fibrosis by metabolic reprogramming of macrophages to acquire anti-inflammatory properties. Cell Mol Gastroenterol Hepatol 16(5):711\u201334","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"1160_CR23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cmet.2022.12.011","volume":"35","author":"O Benichou","year":"2023","unstructured":"Benichou O, Coskun T, Gonciarz MD, Garhyan P, Adams AC, Du Y et al (2023) Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist. Cell Metab 35(2):274-286.e10","journal-title":"Cell Metab"},{"key":"1160_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molmet.2019.01.003","volume":"21","author":"H Frikke-Schmidt","year":"2019","unstructured":"Frikke-Schmidt H, Hultman K, Galaske JW, J\u00f8rgensen SB, Myers MG, Seeley RJ (2019) GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice. Mol Metab 21:13\u201321","journal-title":"Mol Metab"},{"issue":"2","key":"1160_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cmet.2023.01.001","volume":"35","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhao X, Dong X, Zhang Y, Zou H, Jin Y et al (2023) Activity-balanced GLP-1\/GDF15 dual agonist reduces body weight and metabolic disorder in mice and non-human primates. Cell Metab 35(2):287-298.e4","journal-title":"Cell Metab"},{"issue":"1","key":"1160_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5(1):210","journal-title":"Syst Rev"},{"key":"1160_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2024.03.001","author":"J Enr\u00edquez-Schmidt","year":"2024","unstructured":"Enr\u00edquez-Schmidt J, Mautner Molina C, Kalazich Rosales M, Mu\u00f1oz M, Ruiz-Uribe M, Fuentes Leal F et al (2024) Moderate-intensity constant or high-intensity interval training? Metabolic effects on candidates to undergo bariatric surgery. Nutr Metab Cardiovasc Dis.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"1160_CR28","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1530\/EJE-16-0550","volume":"175","author":"MH Schernthaner-Reiter","year":"2016","unstructured":"Schernthaner-Reiter MH, Kasses D, Tugendsam C, Riedl M, Peric S, Prager G et al (2016) Growth differentiation factor 15 increases following oral glucose ingestion: effect of meal composition and obesity. Eur J Endocrinol 175(6):623\u201331","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1160_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12020-023-03435-2","volume":"82","author":"K Chaiyasoot","year":"2023","unstructured":"Chaiyasoot K, Khumkhana N, Deekum W, Chaichana C, Taweerutchana V, Srisuworanan N et al (2023) Alteration of BDNF, SPARC, FGF-21, and GDF-15 circulating levels after 1 year of anti-obesity treatments and their association with 1-year weight loss. Endocrine 82(1):57\u201368","journal-title":"Endocrine"},{"issue":"22","key":"1160_CR30","doi-asserted-by":"publisher","first-page":"14020","DOI":"10.3390\/ijms232214020","volume":"23","author":"A Schmid","year":"2022","unstructured":"Schmid A, Arians M, Burg-Roderfeld M, Karrasch T, Sch\u00e4ffler A, Roderfeld M et al (2022) Circulating Adipokines and Hepatokines Serve as Diagnostic Markers during Obesity Therapy. Int J Mol Sci 23(22):14020","journal-title":"Int J Mol Sci"},{"key":"1160_CR31","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.2147\/JIR.S304929","volume":"14","author":"AA Salman","year":"2021","unstructured":"Salman AA, Shaaban H-D, Salman MA, Seif El Nasr M, Soliman S, Salem A (2021) Changes in plasma growth differentiation factor-15 after laparoscopic sleeve gastrectomy in morbidly obese patients: a prospective study. J Inflamm Res 14:1365\u20131373","journal-title":"J Inflamm Res"},{"issue":"3","key":"1160_CR32","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.amjsurg.2020.01.041","volume":"220","author":"PR Dolo","year":"2020","unstructured":"Dolo PR, Yao L, Liu PP, Widjaja J, Meng S, Li C et al (2020) Effect of sleeve gastrectomy on plasma growth differentiation factor-15 (GDF15) in human. Am J Surg 220(3):725\u201330","journal-title":"Am J Surg"},{"issue":"4","key":"1160_CR33","first-page":"E615","volume":"316","author":"M Kleinert","year":"2019","unstructured":"Kleinert M, Bojsen-M\u00f8ller KN, J\u00f8rgensen NB, Svane MS, Martinussen C, Kiens B et al (2019) Effect of bariatric surgery on plasma GDF15 in humans. Am J Physiol Metab 316(4):E615\u2013E621","journal-title":"Am J Physiol Metab"},{"issue":"2","key":"1160_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1373\/clinchem.2010.153726","volume":"57","author":"G Vila","year":"2011","unstructured":"Vila G, Riedl M, Anderwald C, Resl M, Handisurya A, Clodi M et al (2011) The Relationship between Insulin Resistance and the Cardiovascular Biomarker Growth Differentiation Factor-15 in Obese Patients. Clin Chem 57(2):309\u2013316","journal-title":"Clin Chem"},{"issue":"7","key":"1160_CR35","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3390\/jcm11071756","volume":"11","author":"A Schmid","year":"2022","unstructured":"Schmid A, Arians M, Karrasch T, Pons-K\u00fchnemann J, Sch\u00e4ffler A, Roderfeld M et al (2022) Improvement of Type 2 Diabetes Mellitus and Attenuation of NAFLD Are Associated with the Success of Obesity Therapy. J Clin Med 11(7):1756","journal-title":"J Clin Med"},{"key":"1160_CR36","doi-asserted-by":"crossref","unstructured":"Urones P, Juiz-Vali\u00f1a P, Outeiri\u00f1o-Blanco E, Garc\u00eda-Brao MJ, Balboa-Barreiro V, Cordido F et al (2025) Relevance of GDF15 as a biomarker for clinical outcomes after bariatric surgery. J Endocrinol. ;266(1)","DOI":"10.1530\/JOE-25-0010"},{"issue":"1","key":"1160_CR37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11695-024-07625-3","volume":"35","author":"A Di Vincenzo","year":"2025","unstructured":"Di Vincenzo A, Granzotto M, Trevellin E, Capone F, Prevedello L, Foletto M et al (2025) Sleeve Gastrectomy Preferentially Increases GDF15 Plasma Levels in Patients With Obesity but Without Metabolic Syndrome. Obes Surg 35(1):341\u2013344","journal-title":"Obes Surg"},{"issue":"10","key":"1160_CR38","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41574-021-00529-7","volume":"17","author":"D Wang","year":"2021","unstructured":"Wang D, Day EA, Townsend LK, Djordjevic D, J\u00f8rgensen SB, Steinberg GR (2021) GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. Nat Rev Endocrinol 17(10):592\u2013607","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"1160_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-physiol-022020-045449","volume":"83","author":"SN Breit","year":"2021","unstructured":"Breit SN, Brown DA, Tsai V-W (2021) The GDF15-GFRAL pathway in health and metabolic disease: friend or foe? Annu Rev Physiol 83(1):127\u2013151","journal-title":"Annu Rev Physiol"},{"key":"1160_CR40","doi-asserted-by":"crossref","unstructured":"Tanaka T, Biancotto A, Moaddel R, Moore AZ, Gonzalez-Freire M, Aon MA et al (2018) Plasma proteomic signature of age in healthy humans. Aging Cell. ;17(5)","DOI":"10.1111\/acel.12799"},{"key":"1160_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101569","volume":"75","author":"M Conte","year":"2022","unstructured":"Conte M, Giuliani C, Chiariello A, Iannuzzi V, Franceschi C, Salvioli S (2022) GDF15, an emerging key player in human aging. Ageing Res Rev 75:101569","journal-title":"Ageing Res Rev"},{"key":"1160_CR42","doi-asserted-by":"crossref","unstructured":"Liu W-S, You J, Chen S-D, Zhang Y, Feng J-F, Xu Y-M et al (2024) Plasma proteomics identify biomarkers and undulating changes of brain aging. Nat Aging","DOI":"10.1038\/s43587-024-00753-6"},{"key":"1160_CR43","doi-asserted-by":"crossref","unstructured":"Habibullah M, Jemmieh K, Ouda A, Haider MZ, Malki MI, Elzouki A-N (2024) Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies. Front Med. ;11","DOI":"10.3389\/fmed.2024.1291501"},{"key":"1160_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155694","volume":"148","author":"L Valenzuela-Vallejo","year":"2023","unstructured":"Valenzuela-Vallejo L, Chrysafi P, Kouvari M, Guatibonza-Garcia V, Mylonakis SC, Katsarou A et al (2023) Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: a multicenter observational study. Metabolism 148:155694","journal-title":"Metabolism"},{"issue":"6","key":"1160_CR45","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.cgh.2018.10.017","volume":"17","author":"Y Lee","year":"2019","unstructured":"Lee Y, Doumouras AG, Yu J, Brar K, Banfield L, Gmora S et al (2019) Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 17(6):1040\u20131060e11","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"1160_CR46","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3350\/cmh.2023.0384","volume":"30","author":"J Hwang","year":"2024","unstructured":"Hwang J, Hwang H, Shin H, Kim BH, Kang SH, Yoo J-J et al (2024) Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis. Clin Mol Hepatol 30(3):561\u2013576","journal-title":"Clin Mol Hepatol"},{"issue":"Supplement1","key":"1160_CR47","first-page":"S158","volume":"47","author":"NA ElSayed","year":"2024","unstructured":"ElSayed NA, Aleppo G, Bannuru RR, Bruemmer D, Collins BS, Ekhlaspour L et al (2024) 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes\u20142024. Diabetes Care 47(Supplement1):S158\u2013S178","journal-title":"Diabetes Care"},{"issue":"9","key":"1160_CR48","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.2337\/dci20-0030","volume":"43","author":"WH Herman","year":"2020","unstructured":"Herman WH, Ratner RE (2020) Metformin should be used to treat prediabetes in selected individuals. Diabetes Care 43(9):1988\u20131990","journal-title":"Diabetes Care"},{"issue":"5","key":"1160_CR49","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmv025","volume":"21","author":"N Naderpoor","year":"2015","unstructured":"Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ (2015) Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update 21(5):560\u201374","journal-title":"Hum Reprod Update"},{"issue":"7795","key":"1160_CR50","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","volume":"578","author":"AP Coll","year":"2020","unstructured":"Coll AP, Chen M, Taskar P, Rimmington D, Patel S, Tadross JA et al (2020) GDF15 mediates the effects of metformin on body weight and energy balance. Nature 578(7795):444\u2013448","journal-title":"Nature"},{"issue":"1","key":"1160_CR51","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/s41598-024-51866-2","volume":"14","author":"JWR Kincaid","year":"2024","unstructured":"Kincaid JWR, Rimmington D, Tadross JA, Cimino I, Zvetkova I, Kaser A et al (2024) The gastrointestinal tract is a major source of the acute metformin-stimulated rise in GDF15. Sci Rep 14(1):1899","journal-title":"Sci Rep"},{"issue":"7","key":"1160_CR52","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.tips.2023.04.004","volume":"44","author":"E Barroso","year":"2023","unstructured":"Barroso E, Montori-Grau M, Wahli W, Palomer X, V\u00e1zquez-Carrera M (2023) Striking a gut\u2013liver balance for the antidiabetic effects of metformin. Trends Pharmacol Sci 44(7):457\u2013473","journal-title":"Trends Pharmacol Sci"},{"key":"1160_CR53","doi-asserted-by":"crossref","unstructured":"Mohamed AM, Aljabal H, Alalawi AS, Al-Nooh N (2024) The Impact of Bariatric Surgery on Type 2 Diabetes Mellitus Remission: A Systematic Review. Cureus","DOI":"10.7759\/cureus.74755"},{"key":"1160_CR54","doi-asserted-by":"crossref","unstructured":"Yang Y, Miao C, Wang Y, He J (2024) The long-term effect of bariatric\/metabolic surgery versus pharmacologic therapy in type 2 diabetes mellitus patients: A systematic review and meta\u2010analysis. Diabetes Metab Res Rev. ;40(5)","DOI":"10.1002\/dmrr.3830"},{"issue":"7","key":"1160_CR55","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1210\/clinem\/dgae032","volume":"109","author":"R Sabaratnam","year":"2024","unstructured":"Sabaratnam R, Kristensen JM, Pedersen AJT, Kruse R, Handberg A, Wojtaszewski JFP et al (2024) Acute Exercise Increases GDF15 and Unfolded Protein Response\/Integrated Stress Response in Muscle in Type 2 Diabetes. J Clin Endocrinol Metab 109(7):1754\u20131764","journal-title":"J Clin Endocrinol Metab"},{"key":"1160_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/cdn\/nzaa063_106","volume":"4","author":"H Zhang","year":"2020","unstructured":"Zhang H, Mey J, Champagne C, Kirwan J (2020) Growth differentiation factor 15 is linked to reduced preference for fatty foods in adults with overweight or obesity. Curr Dev Nutr 4:nzaa063_106","journal-title":"Curr Dev Nutr"},{"key":"1160_CR57","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.2147\/DMSO.S302033","volume":"14","author":"L Cai","year":"2021","unstructured":"Cai L, Li C, Wang Y, Mo Y, Yin J, Ma X (2021) Increased serum GDF15 related to improvement in metabolism by lifestyle intervention among young overweight and obese adults. Diabetes Metab Syndr Obes Targets Ther 14:1195\u20131202","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"1160_CR58","doi-asserted-by":"crossref","unstructured":"Conte M, Martucci M, Mosconi G, Chiariello A, Cappuccilli M, Totti V et al (2020) GDF15 Plasma Level Is Inversely Associated With Level of Physical Activity and Correlates With Markers of Inflammation and Muscle Weakness. Front Immunol. ;11","DOI":"10.3389\/fimmu.2020.00915"},{"key":"1160_CR59","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.molmet.2017.12.016","volume":"9","author":"M Kleinert","year":"2018","unstructured":"Kleinert M, Clemmensen C, Sj\u00f8berg KA, Carl CS, Jeppesen JF, Wojtaszewski JFP et al (2018) Exercise increases circulating GDF15 in humans. Mol Metab 9:187\u201391","journal-title":"Mol Metab"},{"issue":"11","key":"1160_CR60","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1007\/s11695-023-06796-9","volume":"33","author":"HN Jung","year":"2023","unstructured":"Jung HN, Kim S-O, Jung CH, Lee WJ, Kim MJ, Cho YK (2023) Preserved muscle strength despite muscle mass loss after bariatric metabolic surgery: a systematic review and meta-analysis. Obes Surg 33(11):3422\u20133430","journal-title":"Obes Surg"},{"key":"1160_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2020.111115","volume":"142","author":"H Kim","year":"2020","unstructured":"Kim H, Kim KM, Kang MJ, Lim S (2020) Growth differentiation factor-15 as a biomarker for sarcopenia in aging humans and mice. Exp Gerontol 142:111115","journal-title":"Exp Gerontol"},{"key":"1160_CR62","doi-asserted-by":"crossref","unstructured":"Kim M, Walston JD, Won CW (2022) Associations Between Elevated Growth Differentiation Factor-15 and Sarcopenia Among Community-dwelling Older Adults. Newman AB, editor. Journals Gerontol Ser A. ;77(4):770\u201380","DOI":"10.1093\/gerona\/glab201"},{"issue":"1","key":"1160_CR63","doi-asserted-by":"publisher","first-page":"7173","DOI":"10.1038\/s41467-024-51078-2","volume":"15","author":"L L\u2019homme","year":"2024","unstructured":"L\u2019homme L, Sermikli BP, Haas JT, Fleury S, Quemener S, Guinot V et al (2024) Adipose tissue macrophage infiltration and hepatocyte stress increase GDF-15 throughout development of obesity to MASH. Nat Commun 15(1):7173","journal-title":"Nat Commun"},{"key":"1160_CR64","doi-asserted-by":"crossref","unstructured":"Townsend LK, Weber AJ, Day EA, Shamshoum H, Shaw SJ, Perry CGR et al (2021) AMPK mediates energetic stress-induced liver GDF15. FASEB J. ;35(1)","DOI":"10.1096\/fj.202000954R"},{"issue":"12","key":"1160_CR65","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.3390\/nu12123771","volume":"12","author":"L L\u2019homme","year":"2020","unstructured":"L\u2019homme L, Sermikli B, Staels B, Piette J, Legrand-Poels S, Dombrowicz D (2020) Saturated fatty acids promote GDF15 expression in human macrophages through the PERK\/eIF2\/CHOP signaling pathway. Nutrients 12(12):3771","journal-title":"Nutrients"},{"issue":"1","key":"1160_CR66","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2337\/db23-0495","volume":"73","author":"D Wang","year":"2024","unstructured":"Wang D, Jabile MJT, Lu J, Townsend LK, Valvano CM, Gautam J et al (2024) Fatty Acids Increase GDF15 and Reduce Food Intake Through a GFRAL Signaling Axis. Diabetes 73(1):51\u201356","journal-title":"Diabetes"},{"issue":"4","key":"1160_CR67","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s11695-015-1829-x","volume":"26","author":"KA Carswell","year":"2016","unstructured":"Carswell KA, Belgaumkar AP, Amiel SA, Patel AG (2016) A systematic review and meta-analysis of the effect of gastric bypass surgery on plasma lipid levels. Obes Surg 26(4):843\u2013855","journal-title":"Obes Surg"},{"issue":"1","key":"1160_CR68","doi-asserted-by":"publisher","first-page":"15337","DOI":"10.1038\/s41598-022-19657-9","volume":"12","author":"SJ Hierons","year":"2022","unstructured":"Hierons SJ, Abbas K, Sobczak AIS, Cerone M, Smith TK, Ajjan RA et al (2022) Changes in plasma free fatty acids in obese patients before and after bariatric surgery highlight alterations in lipid metabolism. Sci Rep 12(1):15337","journal-title":"Sci Rep"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-026-01160-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13105-026-01160-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-026-01160-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:13:39Z","timestamp":1781644419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13105-026-01160-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1160"],"URL":"https:\/\/doi.org\/10.1007\/s13105-026-01160-8","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics"}},{"value":"to participate\n                      .","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"34"}}